A Chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38

Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling

(2020) Jiansheng Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Maigeng Zhou et al.   LANCET

Inflammatory mechanisms in patients with chronic obstructive pulmonary disease

(2016) Peter J. Barnes   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy-oriented compatibility for component-based Chinese medicine

(2015) Jun-hua Zhang et al.   ACTA PHARMACOLOGICA SINICA

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease

(2015) Jiansheng Li et al.   Scientific Reports

Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease

(2014) Ya Li et al.   BMC Complementary and Alternative Medicine

Antitumor effects of dammarane-type saponins from steamed Notoginseng

(2014) Fan He et al.   Pharmacognosy Magazine

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD

(2014) Antonino Di Stefano et al.   THORAX

Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease

(2013) Peter J. Barnes   CLINICS IN CHEST MEDICINE

The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns

(2013) Jian-sheng Li et al.   COMPLEMENTARY THERAPIES IN MEDICINE

Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study

(2012) Su-yun Li et al.   BMC Complementary and Alternative Medicine

p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD

(2012) Audreesh Banerjee et al.   CURRENT OPINION IN PHARMACOLOGY

Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs

(2012) Kate Gaffey et al.   EUROPEAN RESPIRATORY JOURNAL

Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway

(2011) Yeo-Jin Choi et al.   FITOTERAPIA

Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-κB signaling pathway

(2010) Chang-Qing Xu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY